Motif Bio PLC

Motif Bio PLC
Stock Exchange Other OTC
EPS
$0.07
Market Cap
$10.27 M
Shares Outstanding
296.53 M
Public Float
276.45 M
Motif Bio PLC
Stock Exchange London Stock Exchange
EPS
GBP0.05
Market Cap
GBP7.88 M
Shares Outstanding
342.49 M
Public Float
-

Profile

Address
5 Independence Way
Princeton New Jersey 08540
United States
Employees -
Website https://www.motifbio.com/
Updated 07/08/2019
Motif Bio Plc is a clinical stage biopharmaceutical company which develops novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. It pipeline of antibiotics includes iclaprim, and MTF-001, a preclinical program to design a dihydrofolate reductase inhibitor (DHFRi). The company was founded on November 20, 2014 and is headquartered in New York, NY.

Financials

View All

Graham George Lumsden
Chief Executive Officer & Executive Director
Jonathan E. Gold
Chief Financial Officer & Executive Director